World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
69963
World Ranking
8105
National Ranking
249

Overview

Bernard Combe is affiliated with the University of Montpellier in France and has a research focus primarily in Medicine, with a specialization in Rheumatology. Their work extensively covers subfields such as Immunology, Hematology, Genetics, and Pathology and Forensic Medicine.

The scientist's major research topics include:

  • Rheumatoid Arthritis Research and Therapies
  • Spondyloarthritis Studies and Treatments
  • Autoimmune and Inflammatory Disorders Research
  • Chronic Lymphocytic Leukemia Research
  • Psoriasis: Treatment and Pathogenesis
  • Systemic Lupus Erythematosus Research
  • Lymphoma Diagnosis and Treatment

Bernard Combe has contributed to a significant number of publications, with frequent appearances in journals such as:

  • Annals of the Rheumatic Diseases
  • Revue du Rhumatisme
  • Lara D. Veeken
  • RMD Open
  • Arthritis Research & Therapy

Among their recent papers are the following:

  • Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial, 2021, Annals of the Rheumatic Diseases
  • EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2, 2020, Annals of the Rheumatic Diseases
  • Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients, 2020, Annals of the Rheumatic Diseases
  • EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update, 2022, Annals of the Rheumatic Diseases
  • Glucocorticoids in rheumatoid arthritis: current status and future studies, 2020, RMD Open

The scientist collaborates frequently with various other researchers. Prominent co-authors include:

  • Jacques Morel
  • Cédric Lukas
  • Maxime Dougados
  • Bruno Fautrel
  • C. Daïen

Best Publications

  • 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

    Daniel Aletaha;Tuhina Neogi;Alan J. Silman;Julia Funovits

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • Treating rheumatoid arthritis to target: recommendations of an international task force

    Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang

  • Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk

  • EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

    Bernard Combe;Robert Landewé;Cedric Lukas;Horatio D Bolosiu

  • 合成および生物学的疾患修飾性抗リウマチ薬による関節リウマチ管理に関するEULAR(欧州リウマチ学会)推奨事項: 2013年最新情報

    Smolen Josef S;Landewe Robert;Breedveld Ferdinand C;Buch Maya

  • Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

    Edward Keystone;Désireé Van Der Heijde;David Mason;Robert Landewé

  • Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

    Antonio Naranjo;Tuulikki Sokka;Miguel A. Descalzo;Jaime Calvo-Alén

  • Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

    D. Aletaha;R.B. Landewe;T. Karonitsch;J. Bathon

  • 2016 update of the EULAR recommendations for the management of early arthritis

    Bernard Combe;Robert Landewe;Claire I Daien;Charlotte Hua

  • Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

    O Meyer;C Labarre;M Dougados;Ph Goupille

  • Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

    Xavier Mariette;Philippe Ravaud;Serge Steinfeld;Gabriel Baron

  • Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease‐modifying antirheumatic drugs: A one‐year randomized, placebo‐controlled study

    M. Weinblatt;B. Combe;A. Covucci;R. Aranda

  • Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases

    JE Gottenberg;L Guillevin;O Lambotte;B Combe

  • Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

    Benjamin Terrier;Zahir Amoura;Philippe Ravaud;Eric Hachulla

  • Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial.

    Mark C Genovese;Roy Fleischmann;Bernard Combe;Stephen Hall

  • Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study.

    B Combe;M Dougados;P Goupille;A Cantagrel

  • Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry.

    J.-E. Gottenberg;P. Ravaud;T. Bardin;P. Cacoub

Frequent Co-Authors

Maxime Dougados
Maxime Dougados Hôpital Cochin
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Jean Sibilia
Jean Sibilia University of Strasbourg
Bruno Fautrel
Bruno Fautrel Université Paris Cité
Alain Saraux
Alain Saraux University of Western Brittany
Paul Emery
Paul Emery University of Leeds
Laure Gossec
Laure Gossec Sorbonne University
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Philippe Ravaud
Philippe Ravaud Université Paris Cité
Robert Landewé
Robert Landewé University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering alternative or supplementary routes in healthcare, a variety of online degree programs offer accelerated pathways into rewarding careers. If you want to advance quickly, explore the fastest dnp program options—these Doctor of Nursing Practice programs are tailored for experienced nurses seeking leadership or advanced clinical roles on a shorter timeline.

Affordability is also a key factor; those searching for budget-friendly training can consider schools offering the cheapest dnp programs while maintaining academic quality and accreditation. For entry-level roles, the lpn program provides a streamlined, online experience to become a Licensed Practical Nurse, often in under a year.

Mental health is a growing field, with demand for specialists who can address psychological and psychiatric needs. If you want to focus your career here, look into psych np online programs for an expedited route to becoming a Psychiatric Mental Health Nurse Practitioner. Each of these paths provides flexibility, allowing you to balance studies with work or family commitments.

Best Scientists Citing Bernard Combe

Trending Scientists